Log in

Relevant bibliographies by topics / Renovascular disease / Journal articles

To see the other types of publications on this topic, follow the link: Renovascular disease.

Journal articles on the topic 'Renovascular disease'

Author: Grafiati

Published: 11 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Renovascular disease.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Kalra, Philip A. "Renovascular Disease." Medicine 31, no. 7 (July 2003): 116–18. http://dx.doi.org/10.1383/medc.31.7.116.28477.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Kalra, Philip A. "Renovascular disease." Medicine 35, no. 7 (July 2007): 406–9. http://dx.doi.org/10.1016/j.mpmed.2007.04.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Kalra, Philip A. "Renovascular disease." Medicine 39, no. 6 (June 2011): 364–68. http://dx.doi.org/10.1016/j.mpmed.2011.03.007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Vassallo, Diana, and Philip A. Kalra. "Renovascular disease." Medicine 43, no. 7 (July 2015): 419–24. http://dx.doi.org/10.1016/j.mpmed.2015.04.008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Vassallo, Diana, and Philip A. Kalra. "Renovascular disease." Medicine 47, no. 8 (August 2019): 526–32. http://dx.doi.org/10.1016/j.mpmed.2019.05.008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

RANKIN, SHEILA C., ANDREW J. S. SAUNDERS, GARY J. R. COOK, and JOHN E. SCOBLE. "Renovascular Disease." Clinical Radiology 55, no. 1 (January 2000): 1–12. http://dx.doi.org/10.1053/crad.1999.0338.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Matsumoto, Alan H. "Renovascular Disease." Journal of Vascular and Interventional Radiology 14, no. 2 (February 2003): P60—P61. http://dx.doi.org/10.1016/s1051-0443(03)70089-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Libertino, John A. "Renovascular disease." Current Opinion in Urology 3, no. 2 (April 1993): 107–9. http://dx.doi.org/10.1097/00042307-199304000-00010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Hamilton, George. "Renovascular disease." Current Opinion in Urology 4, no. 2 (March 1994): U49. http://dx.doi.org/10.1097/00042307-199403000-00011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Olin, Jeffrey W. "Atherosclerotic renovascular disease." Current Opinion in Cardiology 5, no. 5 (October 1990): 659–65. http://dx.doi.org/10.1097/00001573-199010000-00016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Spitalewitz, Samuel, and Ira W. Reiser. "ATHEROSCLEROTIC RENOVASCULAR DISEASE." American Journal of Therapeutics 3, no. 4 (April 1996): 321. http://dx.doi.org/10.1097/00045391-199604000-00010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Tobe, Sheldon W., Ellen Burgess, and Marcel Lebel. "Atherosclerotic renovascular disease." Canadian Journal of Cardiology 22, no. 7 (May 2006): 623–28. http://dx.doi.org/10.1016/s0828-282x(06)70286-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Cambria, R. P. "Atherosclerotic Renovascular Disease." Perspectives in Vascular Surgery and Endovascular Therapy 16, no. 4 (December 1, 2004): 246–48. http://dx.doi.org/10.1177/153100350401600402.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Scoble, J. E., and G. Hamilton. "Atherosclerotic renovascular disease." BMJ 300, no. 6741 (June 30, 1990): 1670–71. http://dx.doi.org/10.1136/bmj.300.6741.1670.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Zhang, Xin, and Lilach O. Lerman. "Obesity and renovascular disease." American Journal of Physiology-Renal Physiology 309, no. 4 (August 15, 2015): F273—F279. http://dx.doi.org/10.1152/ajprenal.00547.2014.

Full text

Abstract:

Obesity remains a prominent public health concern. Obesity not only contributes greatly to cardiovascular events but has also been identified to initiate and affect the progression of preexisting chronic kidney disease. The prevalence of renal artery stenosis is growing world-wide, especially in the elderly population and in individuals with atherosclerotic risk factors such as obesity. Prolonged renovascular disease causes inflammation and microvascular remodeling within the post-stenotic kidney, which promote tissue scarring and may account for irreversible renal damage. Obesity has been shown to aggravate kidney damage via several pathways, including exacerbation of microvascular regression and renal cell injury mediated by adipocytes and insulin resistance, thereby worsening the structural and functional outcomes of the kidney in renovascular disease. Dietary modification and inhibition of the renin-angiotensin-aldosterone system have been shown to alleviate obesity-induced tissue injury and remodeling. Possibly, angiogenic factors may boost microvascular repair in the ischemic kidney in the obesity milieu. Novel therapeutic interventions targeting deleterious pathways that are activated by obesity and responsible for kidney damage need to be explored in future studies.

APA, Harvard, Vancouver, ISO, and other styles

16

Ingelfinger, Julie R. "Renovascular disease in children." Kidney International 43, no. 2 (February 1993): 493–505. http://dx.doi.org/10.1038/ki.1993.72.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Sidhu, Ravinder, and Mark E. Lockhart. "Imaging of Renovascular Disease." Seminars in Ultrasound, CT and MRI 30, no. 4 (August 2009): 271–88. http://dx.doi.org/10.1053/j.sult.2009.04.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Ingelfinger, Julie R. "Hypertension and renovascular disease." Current Opinion in Pediatrics 2, no. 2 (April 1990): 343–47. http://dx.doi.org/10.1097/00008480-199004000-00024.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Deal, J. E., M. F. Snell, T. M. Barratt, and M. J. Dillon. "Renovascular disease in childhood." Journal of Pediatrics 121, no. 3 (September 1992): 378–84. http://dx.doi.org/10.1016/s0022-3476(05)81789-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

O'Neill, W. Charles, Moreno Bardelli, and Alexander S. Yevzlin. "Imaging For Renovascular Disease." Seminars in Nephrology 31, no. 3 (May 2011): 272–82. http://dx.doi.org/10.1016/j.semnephrol.2011.05.007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Frankel, Andrew, Paul Sweny, Andrew Hilson, L. E. Ramsay, W. W. Yeo, and P. R. Jackson. "Tests for renovascular disease." Lancet 339, no. 8803 (May 1992): 1238. http://dx.doi.org/10.1016/0140-6736(92)91185-b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Fournier, A., R. Makdassi, A. Remond, L. E. Ramsay, W. W. Yeo, and P. R. Jackson. "Tests for renovascular disease." Lancet 339, no. 8808 (June 1992): 1541–42. http://dx.doi.org/10.1016/0140-6736(92)91308-u.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Hélénon, Olivier, Philippe Melki, Jean-Michel Correas, Jean-Christophe Boyer, and Jean-François Moreau. "Renovascular disease: Doppler ultrasound." Seminars in Ultrasound, CT and MRI 18, no. 2 (April 1997): 136–46. http://dx.doi.org/10.1016/s0887-2171(97)90058-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Calligaro, K. D. "Management of Renovascular Disease." Perspectives in Vascular Surgery and Endovascular Therapy 16, no. 1 (March 1, 2004): 1. http://dx.doi.org/10.1177/153100350401600101.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Wood, S. M., C. R. K. Dudley, A. M. Devaney, and C. G. Winearls. "Flosequinan and renovascular disease." Lancet 341, no. 8837 (January 1993): 116–17. http://dx.doi.org/10.1016/0140-6736(93)92595-k.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Bloch, Michael J., and Jan Basile. "Diagnosis and Management of Renovascular Disease and Renovascular Hypertension." Journal of Clinical Hypertension 9, no. 5 (May 2007): 381–89. http://dx.doi.org/10.1111/j.1524-6175.2007.06573.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Sharma, Swapna, Stanislav Henkin, and Michael N. Young. "Renovascular Disease and Mesenteric Vascular Disease." Cardiology Clinics 39, no. 4 (November 2021): 527–37. http://dx.doi.org/10.1016/j.ccl.2021.06.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Takekawa, Soichi D., Shouei Sai, Kenji Kawakura, Yoshikei Miura, Shigeki Imai, and Hirotsugu Munechika. "Renovascular Hypertension." Jurnal Radiologi Indonesia 1, no. 4 (May 1, 2016): 241–55. http://dx.doi.org/10.33748/jradidn.v1i4.33.

Full text

Abstract:

Renovascular hypertension is now a curable disease in most cases by interventional radiological techniques. The authors reviewed diagnostic and therapeutic aspects of renovascular hypertension, focusing on practical points, and introduced several cases of renovascular hypertension, treated by surgery or interventional radiological techniques.

APA, Harvard, Vancouver, ISO, and other styles

29

Barsom, Samer H., Logan M. Glasstetter, Sarosh Siddiqi, Kamalnath Sankaran Rajagopalan, Alfonso Eirin, and Lilach O. Lerman. "Emergent players in renovascular disease." Clinical Science 136, no. 3 (February 2022): 239–56. http://dx.doi.org/10.1042/cs20210509.

Full text

Abstract:

Abstract Renovascular disease (RVD) remains a common etiology of secondary hypertension. Recent clinical trials revealed unsatisfactory therapeutic outcomes of renal revascularization, leading to extensive investigation to unravel key pathophysiological mechanisms underlying irreversible functional loss and structural damage in the chronically ischemic kidney. Research studies identified complex interactions among various players, including inflammation, fibrosis, mitochondrial injury, cellular senescence, and microvascular remodeling. This interplay resulted in a shift of our understanding of RVD from a mere hemodynamic disorder to a pro-inflammatory and pro-fibrotic pathology strongly influenced by systemic diseases like metabolic syndrome (MetS), hypertension, diabetes mellitus, and hyperlipidemia. Novel diagnostic approaches have been tested for early detection and follow-up of RVD progression, using new imaging techniques and biochemical markers of renal injury and dysfunction. Therapies targeting some of the pathological pathways governing the development of RVD have shown promising results in animal models, and a few have moved from bench to clinical research. This review summarizes evolving understanding in chronic ischemic kidney injury.

APA, Harvard, Vancouver, ISO, and other styles

30

Pinto, S., E. Daghini, F. Boresi, A. Virdis, P. Duranti, and A. Salvetti. "HYPEROMOCYSTEINE AND ATHEROSCLEROTIC RENOVASCULAR DISEASE." Journal of Hypertension 22, Suppl. 2 (June 2004): S140. http://dx.doi.org/10.1097/00004872-200406002-00479.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Bittl, John A. "Treatment of Atherosclerotic Renovascular Disease." New England Journal of Medicine 370, no. 1 (January 2, 2014): 78–79. http://dx.doi.org/10.1056/nejme1313423.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Nicholls, Anthony. "Renovascular Disease: The Fifth Frontier." Journal of the Royal Society of Medicine 90, no. 6 (June 1997): 315–18. http://dx.doi.org/10.1177/014107689709000606.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Reidy, J. F., and J. M. Ritter. "Angioplasty in atheromatous renovascular disease." Clinical Radiology 42, no. 5 (November 1990): 299–301. http://dx.doi.org/10.1016/s0009-9260(05)82142-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Main, J., and H. Loose. "Angioplasty in atheromatous renovascular disease." Clinical Radiology 44, no. 2 (August 1991): 139. http://dx.doi.org/10.1016/s0009-9260(05)80521-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Reidy, J. F., and J. M. Ritter. "Angioplasty in atheromatous renovascular disease." Clinical Radiology 44, no. 2 (August 1991): 139–40. http://dx.doi.org/10.1016/s0009-9260(05)80522-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Rees, Chet R. "Stents for Atherosclerotic Renovascular Disease." Journal of Vascular and Interventional Radiology 10, no. 6 (June 1999): 689–705. http://dx.doi.org/10.1016/s1051-0443(99)70103-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Makanjuola, A. D., M. Suresh, P. Laboi, P. A. Kalra, and J. E. Scoble. "Proteinuria in atherosclerotic renovascular disease." QJM 92, no. 9 (September 1, 1999): 515–18. http://dx.doi.org/10.1093/qjmed/92.9.515.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Carr, S. "ACE inhibition and renovascular disease." Diabetic Medicine 18 (January 2001): 4–6. http://dx.doi.org/10.1046/j.1464-5491.2001.00456-3.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Pinto, Stefania, E. Daghini, F. Boresi, A. Virdis, P. Duranti, and A. Salvetti. "HYPERHOMOCYSTEINE AND ATHEROSCLEROTIC RENOVASCULAR DISEASE." Journal of Hypertension 22, Suppl. 1 (February 2004): S38. http://dx.doi.org/10.1097/00004872-200402001-00149.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

CANZANELLO, VINCENT J., and STEPHEN C. TEXTOR. "Noninvasive Diagnosis of Renovascular Disease." Mayo Clinic Proceedings 69, no. 12 (December 1994): 1172–81. http://dx.doi.org/10.1016/s0025-6196(12)65771-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Lagneau, Pierre, and J. B. Michel. "Renovascular Hypertension and Takayasu’s Disease." Journal of Urology 134, no. 5 (November 1985): 876–79. http://dx.doi.org/10.1016/s0022-5347(17)47502-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Wilcox, Christopher S. "Noninvasive evaluation of renovascular disease." Techniques in Vascular and Interventional Radiology 2, no. 2 (June 1999): 60–64. http://dx.doi.org/10.1016/s1089-2516(99)80046-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Lawrie, Gerald M. "Renovascular disease in the elderly." Journal of the American College of Cardiology 7, no. 1 (January 1986): 246. http://dx.doi.org/10.1016/s0735-1097(86)80289-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Dillon, Michael J. "The diagnosis of renovascular disease." Pediatric Nephrology 11, no. 3 (May 26, 1997): 366–72. http://dx.doi.org/10.1007/s004670050300.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Herrera, Angel H., and Richard A. Davidson. "Renovascular Disease in Older Adults." Clinics in Geriatric Medicine 14, no. 2 (May 1998): 237–54. http://dx.doi.org/10.1016/s0749-0690(18)30115-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Kawashima, Akira, Carl M. Sandler, Randy D. Ernst, Eric P. Tamm, Stanford M. Goldman, and Elliot K. Fishman. "CT Evaluation of Renovascular Disease." RadioGraphics 20, no. 5 (September 2000): 1321–40. http://dx.doi.org/10.1148/radiographics.20.5.g00se141321.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Santos Silva, Vanessa, Roberto da Silva Franco, and Luis Martin. "Treatment of Atherosclerotic Renovascular Disease." Current Hypertension Reviews 4, no. 2 (May 1, 2008): 114–20. http://dx.doi.org/10.2174/157340208784245875.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Hansen, Kimberley J., Scott W. Reavis, and Richard H. Dean. "Duplex scanning in renovascular disease." Geriatric Nephrology and Urology 6, no. 2 (1996): 89–97. http://dx.doi.org/10.1007/bf00451112.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Nyvad, Jakob, Amir Lerman, and Lilach O. Lerman. "With a Little Help From My Friends: the Role of the Renal Collateral Circulation in Atherosclerotic Renovascular Disease." Hypertension 79, no. 4 (April 2022): 717–25. http://dx.doi.org/10.1161/hypertensionaha.121.17960.

Full text

Abstract:

The collateral circulation can adapt to bypass major arteries with limited flow and serves a crucial protective role in coronary, cerebral, and peripheral arterial disease. Emerging evidence indicates that the renal collateral circulation can similarly adapt and thereby limit kidney ischemia in atherosclerotic renovascular disease. These adaptations predominantly include recruitment of preexisting microvessels for arteriogenesis, with de novo vessel formation playing a limited role. Yet, adaptations of the renal collateral circulation in renovascular disease are often insufficient to fully compensate for the limited flow within an obstructed renal artery and may be hampered by the severity of obstruction or patient comorbidities. Experimental strategies have attempted to circumvent limitations of collateral formation and improve the prognosis of patients with various ischemic vascular territories. These have included pharmacological approaches such as endothelial growth factors, renin-angiotensin-aldosterone system blockade, and I f channel-blockers, as well as interventions like preconditioning, exercise, enhanced external counter-pulsation, and low-energy shock-wave therapy. However, few of these strategies have been implemented in atherosclerotic renovascular disease. This review summarizes current understanding regarding the development of renal collateral circulation in atherosclerotic renovascular disease. Studies are needed to apply lessons learned in other vascular beds in the setting of atherosclerotic renovascular disease to develop new treatment regimens for this patient group.

APA, Harvard, Vancouver, ISO, and other styles

50

Bosio, Angelo, Flavio Cerrato, and Claudio Pascale. "Resistant hypertension in atherosclerotic renovascular disease." Clinical Management Issues 4, no. 3S (October 13, 2015): 5–10. http://dx.doi.org/10.7175/cmi.v4i3s.1147.

Full text

Abstract:

Resistant hypertension requires careful evaluation for cause assessment. In this report we present a case of renovascular hypertension due to atherosclerotic renal artery stenosis, with particular regard for diagnostic options and therapeutic strategies (medical therapy versus endovascular angioplasty). This case underlines the importance of an adequate evaluation of the patient’s characteristics (i.e age and comorbidities) in order to choose the right strategy.

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!